At PURDYLUCEY, we work with clients across biotech, pharma and food tech to do just that.

Our Life Sciences team combines in-depth sector knowledge and a strong scientific foundation, with backgrounds that span molecular biology, biochemistry, chemistry, and more. The team has specialist attorneys in a range of areas such as peptides/proteins, nucleic acid technology, therapeutics, diagnostics, food technology and microbiology.

Our European Patent Attorneys have experience both in-house and in private practice—giving us a clear understanding of the commercial and regulatory pressures shaping the sector.

We take a proactive, tailored approach to IP strategy—aligning protection with your science, business model, and future goals, whether that’s funding, licensing, or acquisition. That means understanding not just what you’ve developed, but how and when to protect it.

Our support goes beyond drafting and filing. We work closely with clients to anticipate risks, identify opportunities, and ensure their IP strategy is fit for purpose—whether that means aligning with regulatory timelines, supporting investment rounds, or preparing for international expansion. Where additional expertise is needed, we collaborate seamlessly with external specialists to deliver joined-up, commercially focused advice.

Above all, we focus on IP as a commercial asset: helping you protect what matters, maximise long-term value, and accelerate the path from idea to impact.